Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01207791 · ClinicalTrials.gov registry record · NA

Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments

A NA study of Drug Abuse, sponsored by University of New Mexi.

Completed
Registry status
NA
Development phase
1,285
Enrollment target
7
Study locations

NCT01207791 is a NA study of Drug Abuse that has completed, run by University of New Mexi. The registered enrollment target is 1,285 participants, above the 265-participant average among 21 other Drug Abuse trials with a reported enrollment target (385% higher). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01207791, a NA study of Drug Abuse, has completed, sponsored by University of New Mexi.

COMPLETED
Registry status
NA
Development phase
1,285 participants
Enrollment target
7
Study locations

Study Summary

Misuse of drugs and alcohol has a tremendous impact on individual health and on society, in terms of both human suffering and economic cost. Most substance abusers never seek specialty addiction treatment, but a large percentage of them receives some form of medical care, frequently in emergency room settings. There is considerable evidence showing that Screening, Brief Intervention, Referral, and Treatment (SBIRT) interventions in medical settings result in decreased drinking and alcohol-related problems among those with alcohol abuse or dependence. However, there are few studies using these models focusing on drug users. Although drug users are seen in large numbers in emergency departments, there have been no randomized controlled trials of SBIRT models for drug users presenting in Emergency Departments (EDs). This study is designed to assess the effects of Assessment, Referral, and a Brief Intervention on substance use of individuals screening positive for drug use during a medical ED visit. The Southwest Node of the NIDA Clinical Trials Network, located at UNM CASAA, is taking the lead on this study. Six sites across the country will participate in this study, including the ED of UNM Hospital. A total of 1285 ED patients who screen positive for current drug use problems will be randomly assigned to receive 1) minimal screening only, 2) assessment of substance use and referral to treatment, or 3) assessment and referral combined with a 30-minute counseling session (Brief Intervention) and two follow-up telephone counseling sessions. Outcomes will be assessed at 3, 6, and 12 months after the ED visit. We hypothesize that those who receive the Brief Intervention will have the least drug use at follow-up, that those who receive minimal screening only (the usual current practice) will have the most drug use, and that those receiving assessment and referral without the Brief intervention will have intermediate outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL assessment
  • BEHAVIORAL Brief intervention
  • BEHAVIORAL screening
  • BEHAVIORAL referral
  • BEHAVIORAL booster sessions

Study Locations (7)

Florida

  • Jackson Memorial Hospital - Miami

Massachusetts

  • Massachusetts General Hospital - Boston

New Mexico

  • University of New Mexico Hospital - Albuquerque

New York

  • Belleview Hospital - New York

Ohio

  • University of Cincinnati Hospital - Cincinnati

Washington

  • University of Washington - Seattle

West Virginia

  • West Virginia University Hospital - Morgantown

Trial Details

FieldValue
Enrollment Target 1,285 participants
Start Date 2010-10
Est. Completion 2013-03
Phase NA

Sponsor

University of New Mexi

76 total trials

What the Registry Record Tells You About NCT01207791

The ClinicalTrials.gov registry entry for NCT01207791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,285 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 265-participant average among 21 other Drug Abuse trials with a reported enrollment target (385% higher). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Drug Abuse appearing as the primary indexed condition, and to 5 interventions - of which assessment is the first listed.

NCT01207791 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Florida, Massachusetts, New Mexico.

Frequently Asked Questions

What is clinical trial NCT01207791 about?

NCT01207791 is a clinical study titled "Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments". Misuse of drugs and alcohol has a tremendous impact on individual health and on society, in terms of both human suffering and economic cost. Most substance abusers never seek specialty addiction treatment, but a large percentage of them receives some form of medical care, frequently in emergency roo...

What is the current status of trial NCT01207791?

This trial is currently completed. It is a NA study. The enrollment target is 1,285 participants. The study started on 2010-10. Estimated completion is 2013-03.

What conditions does trial NCT01207791 study?

This clinical trial studies the following conditions: Drug Abuse.

What interventions are being tested in trial NCT01207791?

The interventions under investigation include: assessment (BEHAVIORAL), Brief intervention (BEHAVIORAL), screening (BEHAVIORAL), referral (BEHAVIORAL), booster sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT01207791?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01207791 being conducted?

This trial has 7 study locations across Florida, Massachusetts, New Mexico, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.